Analysis of 30 synthetic cannabinoids in oral fluid using liquid chromatography-electrospray ionization tandem mass spectrometry

Drug Testing and Analysis

Volumn 5, Issue 8, 2013, Pages 657-669

  Kneisel, Stefan ^a,b   Auwärter, Volker ^a   Kempf, Jürgen ^a,b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Dr ger DCD 5000; LC ESI MS MS; Oral fluid; Spice; Synthetic cannabinoids

Indexed keywords

BLOOD; DRUG PRODUCTS; ELECTROSPRAY IONIZATION; LIQUID CHROMATOGRAPHY;

'SPICE'; COLLECTION DEVICE; DRÄGER DCD 5000; DRUG TESTING; LC MS/MS(ESI); LC-ESI-MS/MS; LC/ESI-MS/MS; LIQUID CHROMATOGRAPHY ELECTROSPRAY; ORAL FLUIDS; SYNTHETIC CANNABINOID;

MASS SPECTROMETRY;

2 METHYL 3 (1 NAPHTHOYL) 1 PROPYLINDOLE; 3 (1 NAPHTHOYL) 1 PENTYLINDOLE; AB 001; AM 1220; AM 2201; AM 2233; AM 694; CANNABINOID; CRA 13; INDOLE DERIVATIVE; JWH 007; JWH 019; JWH 020; JWH 073; JWH 081; JWH 122; JWH 200; JWH 203; JWH 210; JWH 250; JWH 251; JWH 307; JWH 387; JWH 398; JWH 412; MAM 2201; METHANANDAMIDE; RCS 4; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL ANALYSIS; DRUG SCREENING; ELECTROSPRAY MASS SPECTROMETRY; HUMAN; LIMIT OF DETECTION; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL; TANDEM MASS SPECTROMETRY;

DRÄGER DCD 5000; LC/ESI-MS/MS; ORAL FLUID; SPICE; SYNTHETIC CANNABINOIDS;

ADOLESCENT; ADULT; CANNABINOIDS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; HUMANS; LIMIT OF DETECTION; MALE; MIDDLE AGED; SALIVA; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TANDEM MASS SPECTROMETRY; YOUNG ADULT;

EID: 84882283419     PISSN: 19427603     EISSN: 19427611     Source Type: Journal    
DOI: 10.1002/dta.1429     Document Type: Article

References (52)

1. V. Auwärter, S. Dresen, W. Weinmann, M. Müller, M. Pütz, N. Ferreirós . 'Spice' and other herbal blends: Harmless incense or cannabinoid designer drugs? J. Mass Spectrom. 2009, 44, 832.
2. N. Uchiyama, R. Kikura-Hanajiri, N. Kawahara, Y. Goda . Identification of a cannabimimetic indole as a designer drug in a herbal product. Forensic Toxicol. 2009, 27, 61.
3. R. Lindigkeit, A. Boehme, I. Eiserloh, M. Luebbecke, M. Wiggermann, L. Ernst, et al. Spice: A never ending story? Forensic Sci. Int. 2009, 191, 58.
4. S. Dresen, N. Ferreirós, M. Pütz, F. Westphal, R. Zimmermann, V. Auwärter . Monitoring of herbal mixtures potentially containing synthetic cannabinoids as psychoactive compounds. J. Mass Spectrom. 2010, 45, 1186.
5. F. Westphal, F.D. Sönnichsen, S. Thiemt . Identification of 1-butyl-3-(1-(4-methyl)naphthoyl)indole in a herbal mixture. Forensic Sci. Int. 2012, 215, 8.
6. S. Hudson, J. Ramsey, L. King, S. Timbers, S. Maynard, P.I. Dargan, et al. Use of high-resolution accurate mass spectrometry to detect reported and previously unreported cannabinomimetics in 'herbal high' products. J. Anal. Toxicol. 2010, 34, 252.
7. S. Kneisel, F. Westphal, P. Rösner, V. Brecht, A. Ewald, B. Klein, et al. Cannabimimetics: Mass spectra and IR-ATR spectra of new compounds from the years 2009 and 2010. TIAFT Bull. 2011, 41, 38.
8. L. Ernst, H.-M. Schiebel, C. Theuring, R. Lindigkeit, T. Beuerle . Identification and characterization of JWH-122 used as new ingredient in 'Spice-like' herbal incenses. Forensic Sci. Int. 2011, 208, e31.
9. 35S]GTPγS binding assays. Forensic Toxicol. 2011, 29, 132.
10. J. Nakajima, M. Takahashi, T. Seto, C. Kanai, J. Suzuki, M. Yoshida, et al. Identification and quantitation of two benzoylindoles AM-694 and (4-methoxyphenyl)(1-pentyl-1H-indol-3-yl)methanone, and three cannabimimetic naphthoylindoles JWH-210, JWH-122, and JWH-019 as adulterants in illegal products obtained via the Internet. Forensic Toxicol. 2011, 29, 95.
11. N. Uchiyama, M. Kawamura, R. Kikura-Hanajiri, Y. Goda . Identification and quantitation of two cannabimimetic phenylacetylindoles JWH-251 and JWH-250, and four cannabimimetic naphthoylindoles JWH-081, JWH-015, JWH-200, and JWH-073 as designer drugs in illegal products. Forensic Toxicol. 2011, 29, 25.
12. N. Uchiyama, R. Kikura-Hanajiri, Y. Goda . Identification of a novel cannabimimetic phenylacetylindole, cannabipiperidiethanone, as a designer drug in a herbal product and its affinity for cannabinoid CB1 and CB2 receptors. Chem. Pharm. Bull. 2011, 59, 1203.
13. S. Kneisel, F. Westphal, B. Moosmann, V. Brecht, P. Bisel, C. Vidal, et al. Cannabimimetics II: Mass spectra and ATR-IR spectra of new compounds between the end of 2010 and late 2011. TIAFT Bull. 2011, 41, 29.
14. J. Ammann, O.H. Drummer, D. Gerostamoulos, J. Beyer . Detection of synthetic cannabinoids in biological samples - A Review. TIAFT Bull. 2011, 41, 21.
15. EMCDDA. EMCDDA reporting form on the new drug AM-2232, Forensic Toxicology Department University Medical Center, Freiburg, 2011.
16. P. Jankovics, A. Váradi, L. Tölgyesi, S. Lohner, J. Németh-Palotás, J. Balla . Detection and identification of the new potential synthetic cannabinoids 1-pentyl-3-(2-iodobenzoyl)indole and 1-pentyl-3-(1-adamantoyl)indole in seized bulk powders in Hungary. Forensic Sci. Int. 2012, 214, 27.
17. B. Moosmann, S. Kneisel, U. Girreser, V. Brecht, F. Westphal, V. Auwärter . Separation and structural characterization of the synthetic cannabinoids JWH-412 and 1-[(5-fluoropentyl)-1H-indol-3yl]-(4-methylnaphthalen-1-yl)methanone using GC-MS, NMR analysis and a flash chromatography system. Forensic Sci. Int. 2012, 220, e17.
18. S. Kneisel, F. Westphal, P. Bisel, V. Brecht, S. Broecker, V. Auwärter . Identification and structural characterization of the synthetic cannabinoid 3-(1-adamantoyl)-1-pentylindole as an additive in 'herbal incense'. J. Mass Spectrom. 2012, 47, 195.
19. S. Kneisel, P. Bisel, V. Brecht, S. Broecker, M. Müller, V. Auwärter . Identification of the cannabimimetic AM-1220 and its azepane isomer (N-methylazepan-3-yl)-3-(1-naphthoyl)indole in a research chemical and several herbal mixtures. Forensic Toxicol. 2012, 30, 126.
20. J. Nakajima, M. Takahashi, T. Seto, M. Yoshida, C. Kanai, J. Suzuki, et al. Identification and quantitation of two new naphthoylindole drugs-of-abuse, (1-(5-hydroxypentyl)-1H-indol-3-yl)(naphthalen-1-yl)methanone (AM-2202) and (1-(4-pentenyl)-1H-indol-3-yl)(naphthalen-1-yl)methanone, with other synthetic cannabinoids in unregulated "herbal" products circulated in the Tokyo area. Forensic Toxicol. 2012, 30, 33.
21. N. Uchiyama, M. Kawamura, R. Kikura-Hanajiri, Y. Goda . Identification of two new-type synthetic cannabinoids, N-(1-adamantyl)-1-pentyl-1H-indole-3-carboxamide (APICA) and N-(1-adamantyl)-1-pentyl-1H-indazole-3-carboxamide (APINACA), and detection of five synthetic cannabinoids, AM-1220, AM-2233, AM-1241, CB-13 (CRA-13), and AM-1248, as designer drugs in illegal products. Forensic Toxicol. 2012, 30, 114.
22. L. Ernst, K. Krüger, R. Lindigkeit, H.-M. Schiebel, T. Beuerle . Synthetic cannabinoids in "spice-like" herbal blends: First appearance of JWH-307 and recurrence of JWH-018 on the German market. Forensic Sci. Int. 2012. DOI: 10.1016/j.forsciint.2012.05.027
23. K.G. Shanks, T. Dahn, G. Behonick, A. Terrell . Analysis of first and second generation legal highs for synthetic cannabinoids and synthetic stimulants by ultra-performance liquid chromatography and time of flight mass spectrometry. J. Anal. Toxicol. 2012, 36, 360.
24. K. Simolka, R. Lindigkeit, H.-M. Schiebel, U. Papke, L. Ernst, T. Beuerle . Analysis of synthetic cannabinoids in "spice-like" herbal highs: Snapshot of the German market in summer 2011. Anal. Bioanal. Chem. 2012, 404, 157.
25. R. Kikura-Hanajiri, N. Uchiyama, Y. Goda . Survey of current trends in the abuse of psychotropic substances and plants in Japan. Legal Med. 2012, 13, 109.
26. S. Beuck, I. Möller, A. Thomas, A. Klose, N. Schlörer, W. Schänzer, et al. Structure characterisation of urinary metabolites of the cannabimimetic JWH-018 using chemically synthesised reference material for the support of LC-MS/MS-based drug testing. Anal. Bioanal. Chem. 2011, 401, 493.
27. C.L. Moran, V.-H. Le, K.C. Chimalakonda, A.L. Smedley, F.D. Lackey, S.N. Owen, et al. Quantitative measurement of JWH-018 and JWH-073 metabolites excreted in human urine. Anal. Chem. 2011, 83, 4228.
28. A. Grigoryev, S. Savchuk, A. Melnik, N.j. Moskaleva, J. Dzhurko, M. Ershov, et al. Chromatography-mass spectrometry studies on the metabolism of synthetic cannabinoids JWH-018 and JWH-073, psychoactive components of smoking mixtures. J. Chromatogr. B 2011, 879, 1126.
29. K.C. Chimalakonda, S.M. Bratton, V.-H. Le, K.H.N. Yiew, A. Dineva, C.L. Moran, et al. Conjugation of synthetic cannabinoids, JWH-018 [Naphthalen-1-yl-(1-pentylindol-3-yl)methanone] and JWH-073 [naphthalen-1-yl-(1-butylindol-3-yl)methanone], metabolites by human UDP-glucuronosyltransferases. Drug Metab. Dispos. 2011. DOI: 10.1124/dmd.111.040709
30. M.A. ElSohly, W. Gul, K.M. ElSohly, T.P. Murphy, V.L.M. Madgula, S.I. Khan . Liquid chromatography-tandem mass spectrometry analysis of urine specimens for K2 (JWH-018) metabolites. J. Anal. Toxicol. 2011, 35, 487.
31. I. Möller, A. Wintermeyer, K. Bender, M. Jübner, A. Thomas, O. Krug, et al. Screening for the synthetic cannabinoid JWH-018 and its major metabolites in human doping controls. Drug Test. Anal. 2010, 3, 609.
32. A. Grigoryev, P. Kavanagh, A. Melnik . The detection of the urinary metabolites of 3-[(adamantan-1-yl)carbonyl]-1-pentylindole (AB-001), a novel cannabimimetic, by gas chromatography-mass spectrometry. Drug Test. Anal. 2012, 4, 519.
33. T. Sobolevskii, I. Prasolov, G. Rodchenkov . Application of mass spectrometry to the structural identification of the metabolites of the synthetic cannabinoid JWH-018 and the determination of them in human urine. J. Anal. Chem. 2011, 66, 1314.
34. M. Hutter, S. Broecker, S. Kneisel, V. Auwärter . Identification of the major urinary metabolites in man of seven synthetic cannabinoids of the aminoalkylindole type present as adulterants in 'herbal mixtures' using LC-MS/MS techniques. J. Mass Spectrom. 2012, 47, 54.
35. K.A. Seely, L.K. Brents, A. Radominska-Pandya, G.W. Endres, G.S. Keyes, J.H. Moran, et al. A major glucuronidated metabolite of JWH-018 is a neutral antagonist at CB1 receptors. Chem. Res. Toxicol. 2012, 25, 825.
36. A. Grigoryev, P. Kavanagh, A. Melnik . The detection of the urinary metabolites of 1-[(5-fluoropentyl)-1H-indol-3-yl]-(2-iodophenyl)methanone (AM-694), a high affinity cannabimimetic, by gas chromatography - mass spectrometry. Drug Test. Anal. 2012. DOI: 10.1002/dta.1336
37. P. Kavanagh, A. Grigoryev, A. Melnik, A. Simonov . The Identification of the urinary metabolites of 3-(4-Methoxybenzoyl)-1-Pentylindole (RCS-4), a novel cannabimimetic, by gas chromatography-mass spectrometry. J. Anal. Toxicol. 2012, 36, 303.
38. M.A. Neukamm, T.E. Muerdter, C. Kabbe, H. Wehner, F. Wehner . Quantitative detection of the active "Spice" ingredient JWH-018 in serum by means of liquid chromatography-tandem mass spectrometry. Blutalkohol 2009, 46, 373.
39. J. Teske, J.-P. Weller, A. Fieguth, T. Rothämel, Y. Schulz, H.D. Tröger . Sensitive and rapid quantification of the cannabinoid receptor agonist naphthalen-1-yl-(1-pentylindol-3-yl)methanone (JWH-018) in human serum by liquid chromatography-tandem mass spectrometry. J. Chromatogr. B 2010, 878, 2659.
40. S. Dresen, S. Kneisel, W. Weinmann, R. Zimmermann, V. Auwärter . Development and validation of a liquid chromatography-tandem mass spectrometry method for the quantitation of synthetic cannabinoids of the aminoalkylindole type and methanandamide in serum and its application to forensic samples. J. Mass Spectrom. 2011, 46, 163.
41. S.L. Kacinko, A. Xu, J.W. Homan, M.M. McMullin, D.M. Warrington, B.K. Logan . Development and validation of a liquid chromatography-tandem mass spectrometry method for the identification and quantification of JWH-018, JWH-073, JWH-019, and JWH-250 in human whole blood. J. Anal. Toxicol. 2011, 35, 386.
42. K.G. Shanks, T. Dahn, A.R. Terrell . Detection of JWH-018 and JWH-073 by UPLC-MS-MS in postmortem whole blood casework. J. Anal. Toxicol. 2012, 36, 145.
43. J. Ammann, J.M. McLaren, D. Gerostamoulos, J. Beyer . Detection and quantification of new designer drugs in human blood: Part 1 - Synthetic cannabinoids. J. Anal. Toxicol. 2012, 36, 372.
44. S. Kneisel, V. Auwärter . Analysis of 30 synthetic cannabinoids in serum by liquid chromatography-electrospray ionization tandem mass spectrometry after liquid-liquid extraction. J. Mass Spectrom. 2012, 47, 825.
45. A. Salomone, E. Gerace, F. D'Urso, D. Di Corcia, M. Vincenti . Simultaneous analysis of several synthetic cannabinoids, THC, CBD and CBN, in hair by ultra-high performance liquid chromatography tandem mass spectrometry. Method validation and application to real samples. J. Mass Spectrom. 2012, 47, 604.
46. M. Hutter, S. Kneisel, V. Auwärter, M.A. Neukamm . Determination of 22 synthetic cannabinoids in human hair by liquid chromatography-tandem mass spectrometry. J. Chromatogr. B 2012, 903, 95.
47. C. Coulter, M. Garnier, C. Moore . Synthetic cannabinoids in oral fluid. J. Anal. Toxicol. 2011, 35, 424.
48. S. Strano-Rossi, L. Anzillotti, E. Castrignanò, F.S. Romolo, M. Chiarotti . Ultra high performance liquid chromatography-electrospray ionization-tandem mass spectrometry screening method for direct analysis of designer drugs, "spice" and stimulants in oral fluid. J. Chromatogr. A 2012, 1258, 37.
49. J. Kempf, T. Wuske, R. Schubert, W. Weinmann . Pre-analytical stability of selected benzodiazepines on a polymeric oral fluid sampling device. Forensic Sci. Int. 2009, 186, 81.
50. EMCDDA. EMCDDA reporting form on the new drug WIN 55, 212-2, Scientific Investigation Group, Carabinieri of Parma and Custom Agency - Laboratory of Naples, Naples, 2012.
51. F.T. Peters, M. Hartung, M. Herbold, G. Schmitt, T. Daldrup, F. Mußhoff . Anhang B zu den Richtlinien der GTFCh zur Qualitätssicherung bei forensisch-toxikologischen Untersuchungen; Anforderungen an die Validierung von Analysenmethoden. Toxichem. Krimtech. 2009, 76, 185.
52. B.K. Matuszewski, M.L. Constanzer, C.M. Chavez-Eng . Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Anal. Chem. 2003, 75, 3019.